Skip to main content

Roser Solans Laque

Institutions of which they are part

Systemic Diseases
Vall Hebron Institut de Recerca

Roser Solans Laque

Institutions of which they are part

Systemic Diseases
Vall Hebron Institut de Recerca

Research lines

Development and validation of a consensus of a systemic disease activity index for primary Sjögren’s syndrome. EULAR Sjögren’s Task Force.

We are currently enrolled in this multicentre study supported by the “EULAR Sjögren’s Task  Force”  to elaborate and agree on a systemic disease activity index for patients with primary Sjögren’s syndrome, that will be useful in the management of the disease. This study is coordinated by Dr. Raphaele Seror from the “Service de Rheumatologie Hôpital Bicêtre”, France.

IP: Roser Solans Laque

Spanish Registry of patients with primary Sjögren’s syndrome.

This is a multicentre study supported by the Systemic Autoimmune Diseases Group (GEAS) from the Spanish Internal Medicine Society (SEMI). Its main goal consist in investigate the factors involved in extraglandular development in our country. This study is coordinated by Dr. Manel Ramos  from the Clinic Hospital, Barcelona.

IP: Roser Solans Laque

Spanish Registry of patients with Behçet disease (REGEB).

This is a multicentre study supported by the Systemic Autoimmune Diseases Group from the Spanish Internal Medicine Society. The aim of the study is to describe the different clinical forms of disease presentation in our country and the response of the disease to conventional treatment.

IP: Roser Solans Laque

Capillaroscopy abnormalities in primary Sjögren’s syndrome.

We want to describe the capillaroscopy alterations observed in patients with Raynaud's phenomenon and primary Sjögren’s syndrome. Our main objective is to establish if there is a specific capillaroscopic pattern associated with Sjögren syndrome and if it is related to visceral extraglandular involvement.

IP: Roser Solans Laque, Vicenç Fonollosa Pla

Projects

Ajuts Grups de Recerca (SGR) 2022

IP: Jaume Alijotas Reig
Collaborators: Moisés Labrador Horrillo, Carmen Pilar Simeón i Aznar, Anna Sala Cunill, Roser Solans Laque, Segundo Bujan Rivas, Mar Guilarte Clavero, Vicenç Fonollosa Pla, Fernando Martínez Valle, Victòria Cardona Dahl, Francesc Miro Mur, Alfredo Guillen Del Castillo, Albert Selva O'Callaghan, José Pardos Gea, Laura Donaire Lancharro, Ariadna Anunciacion Llunell
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00048
Duration: 01/01/2022 - 30/06/2025

Autoimmunitat i Malaltia Trombòtica (GRC)

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Albert Selva O'Callaghan, Cristina Solé Marce
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 329
Duration: 01/01/2014 - 31/12/2016

Estudio clínico e inmunológico de la afección cardíaca en fase de remisión clínica de la Poliangeítis con Granulomatosis eosinofílica

IP: Roser Solans Laque
Collaborators: -
Funding agency: Mutual Mèdica de Catalunya i Balears
Funding: 4000
Reference: 2014\BMM\SOLANS
Duration: 27/11/2014 - 26/11/2015

Determinación del riesgo de afectación extraglandular y desarrollo de linfoma en el Síndrome de Sjögren primario mediante estudio de poblaciones linfocitarias y citocinas en sangre y tejido

IP: Roser Solans Laque
Collaborators: Carlos Palacio García, Margarita Alberola Ferranti, Fernando Martínez Valle
Funding agency: Instituto de Salud Carlos III
Funding: 35695
Reference: PI13/00655
Duration: 01/01/2014 - 30/06/2018

Related news

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

It will allow the promotion of research on systemic autoimmune-based diseases that especially affect women of childbearing age and, therefore, can also appear during pregnancy.

Related professionals

García Adán, Bernat

García Adán, Bernat

Predoctoral researcher
Neuromuscular and Mitochondrial Pathology
Read more
Paula Granado Martinez

Paula Granado Martinez

Postdoctoral researcher
Biomedical Research in Melanoma
Read more
Piazuelo Espinosa, Sergi

Piazuelo Espinosa, Sergi

Shock, Organ Dysfunction and Resuscitation
Read more
Roberto Vélez Villa

Roberto Vélez Villa

Head of group
Musculoskeletal Tissue Engineering
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.